MEPTID

This brand name is authorized in Ireland, UK.

Active ingredients

The drug MEPTID contains one active pharmaceutical ingredient (API):

1
UNII T62FQ4ZCPA - MEPTAZINOL HYDROCHLORIDE
 

Meptazinol is a centrally acting analgesic belonging to the hexahydroazepine series, which has demonstrated mixed agonist and antagonist activity at opioid receptors. It is used for the short term treatment of moderate pain.

 
Read more about Meptazinol

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 MEPTID Film-coated tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 MEPTID Solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N02AX05 N Nervous system → N02 Analgesics → N02A Opioids → N02AX Other opioids
Discover more medicines within N02AX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
GB Medicines & Healthcare Products Regulatory Agency 26783, 28176
IE Health Products Regulatory Authority 51624, 51675, 51721

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.